Thursday, July 15, 2010

Topiramate not recommended for treatment of obesity

http://www.apmhealtheurope.com/story.php?mots=TOPIRAMATE&searchScope=1&searchType=0&numero=L7098

Topiramate is one of two generic compounds in Qnexa, the other being phentermine. Qnexa is being reviewed by an independent advisory committee today, and will receive full review by the FDA on October 28. Draw your own conclusions.

Disclosure: no position in VVUS.

No comments:

Post a Comment